Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11643434 Neuroactive steroids and compositions thereof

Patent 11643434 was granted and assigned to SAGE Therapeutics on May, 2023 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

SAGE Therapeutics

Current Assignee

SAGE Therapeutics

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

116434340

Patent Inventor Names

Francesco G. Salituro0

Maria Jesus Blanco-Pillado0

Marshall Lee Morningstar0

Date of Patent

May 9, 2023

Patent Application Number

168878870

Date Filed

May 29, 2020

Patent Citations

‌

US Patent 10246482 Neuroactive steroids, compositions, and uses thereof

‌

US Patent 11241446 19-nor C3, 3-disubstituted C21-N-pyrazolyl steroids and methods of use thereof

Patent Citations Received

‌

US Patent 11827634 Small molecule inhibitors of NF-kB inducing kinase

‌

US Patent 11999765 Neuroactive steroids and their methods of use

‌

US Patent 11970514 Neuroactive steroids and their methods of use

‌

US Patent 11912738 Neuroactive steroids and their methods of use

Patent Primary Examiner

CPC Code

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11643434 Neuroactive steroids and compositions thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API